#PediatricAllergy
LightNews LightNews
hisashiohseto.bsky.social
【New paper】
In the first large-scale study from Japan 🇯🇵, higher residential greenness🌿 was associated with a lower risk of atopic dermatitis up to age 5.
Satellite-derived NDVI 🛰️ and a birth cohort of 14,932 children
onlinelibrary.wiley.com/doi/10.1111/...

#PediatricAllergy #GIS #ToMMo
Residential greenness and atopic dermatitis in Japanese children: Findings from the TMM BirThree cohort study
Background Atopic dermatitis (AD) is a chronic inflammatory skin disease that primarily develops during childhood. Residential greenness has been reported to be associated with AD onset. However, fi.....
onlinelibrary.wiley.com
April 7, 2026 at 1:16 PM
aaaaiorg.bsky.social
Lamya Jaigirdar, DO, and Rachel Kado, MD, discuss new findings on oral immunotherapy for pediatric food allergy. https://ow.ly/fV5S50XrToT

#MedicalResearch #PediatricAllergy
Oral Immunotherapy Helps Many Kids Lose Food Allergies, Studies Say
MONDAY, Nov. 10, 2025 (HealthDay News) — Evidence is mounting that oral immunotherapy can help many children shake off food allergies.Children benefited from be
ow.ly
November 14, 2025 at 9:01 PM
hcplivenews.bsky.social
Multi-omics profiling links regulatory T-cell activity, B-cell suppression, and gastrointestinal immune regulation to peanut oral immunotherapy success. #PediatricAllergy #PeanutOIT #Immunology
Peanut Oral Immunotherapy Response Linked to Gut Immunity in Children
Research links Treg activity, B-cell suppression, and gastrointestinal immune regulation to the success and failure of peanut oral immunotherapy.
www.hcplive.com
August 30, 2025 at 12:00 PM
liamgubbels.bsky.social
Excited to share our latest publication titled "New insights into the mechanisms of childhood food allergies" in Pediatric Allergy and Immunology

#foodallergy #PediatricAllergy #oralimmunotherapy #allergy #Pediatrics

onlinelibrary.wiley.com/doi/10.1111/...
New insights into the mechanisms of childhood food allergies
IgE-mediated food allergies are common and can be life-threatening, especially for children. With increasingly rapid advances in immunological technologies, including the ability to profile highly co....
onlinelibrary.wiley.com
April 10, 2025 at 12:52 AM
mdspirenews.bsky.social
The FDA has expanded the approval of Odactra, a sublingual immunotherapy tablet, to include children aged 5-11 with house dust mite allergies. A new treatment option is now available for pediatric patients. Learn more about this approval. #PediatricAllergy #MedSky
FDA Approves Odactra for Pediatric House Dust Mite Allergy
FDA expands Odactra approval to children aged five to 11 for house dust mite allergy.
conexiant.com
February 28, 2025 at 4:26 PM